Thermo Fisher (NYSE: TMO) CEO receives new stock and option awards
Rhea-AI Filing Summary
Thermo Fisher Scientific Chairman & CEO Marc N. Casper reported equity awards tied to performance and long-term incentives. He acquired 32,109 stock options at an exercise price of $0.00 per share, which vest in four equal annual installments beginning on February 28, 2027.
He also acquired 7,515 and 7,333 shares of common stock through performance-based restricted stock unit awards granted in February 2025, after the compensation committee determined on February 25, 2026 that performance criteria were satisfied. One-third of these shares vest on February 28, 2026 and February 28, 2027, with the remaining one-third vesting on February 28, 2028 subject to adjustment based on relative total shareholder return CAGR.
The filing also lists indirect holdings in Thermo Fisher shares by the Alison Casper 2020 Irrevocable Trust, Floral Park Associates, Inc., and the MNC 2020 Irrevocable Trust, for which Casper disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 32,109 | $0.00 | -- |
| Grant/Award | Common Stock | 7,515 | $0.00 | -- |
| Grant/Award | Common Stock | 7,333 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Shares represent a performance-based restricted stock unit award granted on February 19, 2025. The Company's Compensation Committee determined on February 25, 2026, that the performance criteria related to this award were satisfied. One-third of the shares vest on February 28, 2026 and 2027. The remaining one-third will vest on February 28, 2028, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2025, through to December 31, 2027. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. The option vests in four equal annual installments beginning on February 28, 2027.
